About Sangyeul Han
Form D filings for Ingenia Therapeutics from 2019 to 2024 list Sangyeul Han as president and director.
Sangyeul Han first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Sangyeul Han in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sangyeul Han works with at each company, as listed on that company's latest Form D.
Ingenia Therapeutics Inc. · Form D, Jun 21, 2024